Abstract:Successfully reprogramming somatic cells to a pluripotent state generates induced pluripotent stem (iPS) cells (or iPSCs), which have extensive self-renewal capacity like embryonic stem cells (ESCs). iPSCs can also generate daughter cells that can further undergo differentiation into various lineages or terminally differentiate to reach their final functional state. The discovery of how to produce iPSCs opened a new field of stem cell research with both intellectual and therapeutic benefits. The huge potential implications of disease-specific or patient-specific iPSCs have impelled scientists to solve problems hindering their applications in clinical medicine, especially the issues of convenience and safety. To determine the range of tissue types amenable to reprogramming as well as their particular characteristics, cells from three embryonic germ layers have been assessed, and the advantages that some tissue origins have over fibroblast origins concerning efficiency and accessibility have been elucidated. To provide safe iPSCs in an efficient and convenient way, the delivery systems and combinations of inducing factors as well as the chemicals used to generate iPSCs have also been significantly improved in addition to the efforts on finding better donor cells. Currently, iPSCs can be generated without c-Myc and Klf4 oncogenes, and non-viral delivery integration-free chemically mediated reprogramming methods have been successfully employed with relatively satisfactory efficiency. This paper will review recent advances in iPS technology by highlighting tissue origin and generation of iPSCs. The obstacles that need to be overcome for clinical applications of iPSCs are also discussed.

Enhancing Pluripotency and Lineage Specification

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Association of Telomere Length with Authentic Pluripotency of ES/iPS Cells.

Computer and Statistical Analysis of Transcription Factor Binding and Chromatin Modifications by ChIP-seq Data in Embryonic Stem Cell

Global identification of transcriptional regulators of pluripotency and differentiation in embryonic stem cells.

Research progress on the key transcription factors governing the self-renewal of embryonic stem cells

A Transcriptional Roadmap to the Induction of Pluripotency in Somatic Cells

Defining Essential Enhancers for Pluripotent Stem Cells Using a Features-Oriented CRISPR-Cas9 Screen

Improving the Reprogramming Efficiency of Somatic Cells to Induced Pluripotent Stem Cells.

Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells

Tackling the Epigenome in the Pluripotent Stem Cells

Cell Cycle and Pluripotency: Convergence on Octamer-Binding Transcription Factor 4 (Review)

Micro-management of Pluripotent Stem Cells.

Molecular Mechanisms of Pluripotency and Reprogramming

The function and mechanism of epigenetic regulation in the control of embryonic stem cell fate

Signaling networks in the control of pluripotency

Lineage Specifiers: New Players in the Induction of Pluripotency

Challenges to the Clinical Application of Pluripotent Stem Cells: Towards Genomic and Functional Stability.

An Extended Transcriptional Network for Pluripotency of Embryonic Stem Cells.

Large noncoding RNAs are promising regulators in embryonic stem cells

Pluripotency Factors on Their Lineage Move